Experts Assess ACS Cancer Screening Recommendations
A new article supports the recent changes made by the American Cancer Society in its recommendations for breast cancer screening. The new recommendations have modified the suggested ages for annual and biannual mammography and have also focused on patient preferences in decision making.
The three primary recommendations by the ASC included:
1. Annual screening to begin at age 45 with no objections to begin as early as 40.
2. Biannual screening starting at age 55 and the option to continue with annual screening if preferred.
3. Discontinued use of clinical breast examinations as a screening mechanism for women at any age.
When it comes to breast cancer screening practices, it is important to have a delicate balance between the dangers of insufficient monitoring and unnecessary testing. The primary dangers of insufficient monitoring are failing to know if a woman has cancer and delaying treatment while the dangers of unnecessary testing include an increased exposure to radiation and unnecessary false positives.
The article talks about the important differences between the sensitivity and false positive rates for mammography. While mammography detects 84 percent of breast cancers in asymptomatic women, nearly 95 percent of all positive mammograms are false positives.
"Our goal was to caution asymptomatic women that positive mammograms are vastly more likely to be false positives than actual evidence of cancer," said Dr. William Skorupski, co-author of the Significance article. "For most women, a false positive mammogram is about 19 times more likely than a true positive," added co-author Dr. Howard Wainer.
Image Credit: Wikimedia Commons
Published on : Tue, 9 Aug 2016
Sectra offers solutions for capturing, storing and accessing virtually all images, video, audio and documents. Sectra VNA allows you to consolidate image handling, while ensuring clinical workflow efficiency, growth management and business continuity...
The iViz is a lightweight Point Of Care (POC) ultrasound solution, specifically designed for emerging sub-segments where there is need for a highly accessible and mobile solution that is capable throughout key areas of the patient care path. The iViz...
Digital electrocardiograph / 12-channel / with touchscreen CARDIOVIT FT-1 SCHILLER
Maximum performance in a compact electrocardiograph
SCHILLER’s latest innovation is ultra portable, has an intuitive 8-inch high-resolution multi-touch screen, an integrated thermal printer and is FDA approved. Designed for users who value state-of-the-art technology, the CARDIOVIT FT-1 is a networked...
Introducing a new chapter in ultrasound visualization technology. X-Porte was developed from the ground up to incorporate a breakthrough, proprietary beam-forming technology: XDI (Extreme Definition Imaging). This signal analysis algorithm shapes...
Powered by the most revolutionary ZONE Sonography® Technology, Resona 7’s new ZST+ platform brings the ultrasound image quality to a higher level by zone acquisition and channel data processing. Resona 7 also provides clinical research with the revolutionary...